Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder characterised by an unusual sensitivity of abnormal red cell population(s) to complement lysis, due to a complete or incomplete defect of various surface molecules, including CD55 and CD59. PNH has been associated with various hematological disorders. Using a newly introduced method, the Sephacryl gel test microtyping system, we investigated the presence of CD55 or CD59 defective red cell populations in several hematological disorders. It was also found that a large proportion of such patients possess CD55 deficient populations, while a smaller but still significant proportion possess CD59 deficient populations. Defective red cell populations were detected in normal subjects as well. These findings need further investigation. Nevertheless the Sephacryl Gel Test microtyping system although non specific, seems to be useful in screening for the PNH and/or "PNH-like" red cell defect in several hematological disorders.

[1]  L Luzzatto,et al.  The dual pathogenesis of paroxysmal nocturnal hemoglobinuria , 1997, Current opinion in hematology.

[2]  N. Young,et al.  Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. , 1995, Blood.

[3]  S M Lewis,et al.  Natural history of paroxysmal nocturnal hemoglobinuria. , 1995, The New England journal of medicine.

[4]  R. Ware,et al.  The molecular basis of paroxysmal nocturnal hemoglobinuria. , 1995, Blood.

[5]  R. Schmidt,et al.  Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. , 1995, Blood.

[6]  F. Sigaux,et al.  Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. , 1995, Blood.

[7]  K. Takatsuki,et al.  Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia. , 1995, Blood.

[8]  T. Chan,et al.  Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria. , 1994, American journal of clinical pathology.

[9]  E. Vellenga,et al.  Myelodysplasia following paroxysmal nocturnal haemoglobinuria: evidence for the emergence of a separate clone , 1994, British journal of haematology.

[10]  L. Luzzatto,et al.  Myelodysplasia in a patient with pre‐existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease , 1994, British journal of haematology.

[11]  L. Luzzatto,et al.  Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria , 1994, The Lancet.

[12]  T. Miyata,et al.  Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG‐A gene. , 1994, The EMBO journal.

[13]  L. Terstappen,et al.  Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria , 1993, British journal of haematology.

[14]  J. Muller,et al.  Diagnostic rapide des hémoglobinuries nocturnes paroxystiques par agglutination en gel , 1993 .

[15]  Teruo Yamada,et al.  Decay‐accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia , 1993, British journal of haematology.

[16]  J. Harousseau,et al.  Hémoglobinurie nocturne paroxystique : diagnostic à l'aide d'un anticorps monoclonal dirigé contre la glycoprotéine Decay accelerating factor , 1993 .

[17]  B. Nilsson,et al.  A Simplified Assay for the Specific Diagnosis of Paroxysmal Nocturnal Hemoglobinuria: Detection of DAF(CD55)‐ and HRF20(CD59)‐ Erythrocytes in Microtyping Cards , 1993, Vox sanguinis.

[18]  D. Gastineau,et al.  Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy. , 1992, The American journal of medicine.

[19]  L. Terstappen,et al.  Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation , 1992, Journal of leukocyte biology.

[20]  J. Tooze,et al.  Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. , 1991, Blood.

[21]  C. Parker,et al.  Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. , 1991, Blood.

[22]  W. Rosse Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria , 1990 .

[23]  D Josef,et al.  The gel test: a new way to detect red cell antigen‐antibody reactions , 1990, Transfusion.

[24]  L. Luzzatto,et al.  7 Paroxysmal nocturnal haemoglobinuria , 1989 .

[25]  T. Christou,et al.  Paroxysmal nocturnal hemoglobinuria preceding malignant lymphoma. , 1987, Archives of internal medicine.

[26]  D. Devine,et al.  Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone. , 1987, The Journal of clinical investigation.

[27]  G. Omura Coexistence of paroxysmal nocturnal hemoglobinuria and chronic lymphocytic leukemia , 1981, American journal of hematology.

[28]  L. Luzzatto,et al.  The PNH abnormality in myeloproliferative disorders: association of PNH and acute erythremic myelosis in two children. , 1979, Haematologica.

[29]  M. Kruatrachue,et al.  Paroxysmal Nocturnal Haemoglobinuria in Thailand with Special Reference to an Association with Aplastic Anaemia , 1978, British journal of haematology.

[30]  Dacie Jv,et al.  Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. , 1972, Series haematologica.

[31]  N. E. Hansen,et al.  Paroxysmal nocturnal hemoglobinuria in myelofibrosis. , 1970, Blood.

[32]  L Luzzatto,et al.  Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. , 1970, Blood.

[33]  S. Lewis,et al.  The Aplastic Anaemia–Paroxysmal Nocturnal Haemoglobinuria Syndrome , 1967, British journal of haematology.